Literature DB >> 29962344

Impact of the Presence of Select Cardiovascular Risk Factors on Cognitive Changes among Dementia Subtypes.

Katherine E Irimata1, Brittany N Dugger2, Jeffrey R Wilson3.   

Abstract

BACKGROUND: Studies have shown select associations between cardiovascular risk factors and dementia, but mostly focused on Alzheimer's Disease (AD).
OBJECTIVE: We enhance these works by evaluating the relationship between the presence of cardiovascular risk factors and the rate of cognitive decline, measured using the Mini-Mental State Examination (MMSE) and Clinical Dementia Rating Sum of Boxes (CDR-SUM) on four common dementia subtypes (AD, dementia with Lewy bodies (DLB), frontotemporal dementia (FTD), and vascular dementia (VaD), as well as non-demented elderly individuals (normal)).
METHOD: We used generalized linear mixed models with random intercepts to account for correlation at the patient and center levels for each dementia subtype adjusting for time since initial visit, baseline cognitive score, age, and demographic factors. The cardiovascular risk factors evaluated included body mass index, diabetes, years of smoking, atrial fibrillation, hypertension, and hypercholesterolemia.
RESULTS: Patients diagnosed with AD (n=1899), DLB (n=65), FTD (n=168), or VaD (n=13); or lacked cognitive impairment (normal) (n=3583) were evaluated using data from the National Alzheimer's Coordinating Centers. Cardiovascular risk factors were associated with select dementia subtypes including AD and FTD. Using MMSE and CDR-SUM, recent or active hypertension and hypercholesterolemia were associated with a slower cognitive decline for AD patients, while higher body mass index and years of smoking were associated with a slower cognitive decline for FTD patients. However, several cardiovascular factors demonstrated associations with more rapid cognitive decline.
CONCLUSION: These results demonstrate disease specific associations and can provide clinicians guidance on predicted cognitive changes at the group level using information about cardiovascular risk factors. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alzheimer`s disease; body mass index; dementia with Lewy bodies; frontotemporal dementia; neuropsychological tests; vascular riskzzm321990factors.

Mesh:

Year:  2018        PMID: 29962344      PMCID: PMC6162109          DOI: 10.2174/1567205015666180702105119

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  65 in total

1.  Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors:  L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal:  Neurobiol Aging       Date:  2000 Jan-Feb       Impact factor: 4.673

Review 2.  Defective Insulin Signalling, Mediated by Inflammation, Connects Obesity to Alzheimer Disease; Relevant Pharmacological Therapies and Preventive Dietary Interventions.

Authors:  Arantxa Rodriguez-Casado; Adolfo Toledano-Díaz; Adolfo Toledano
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

Review 3.  Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies.

Authors:  K J Anstey; N Cherbuin; M Budge; J Young
Journal:  Obes Rev       Date:  2011-02-23       Impact factor: 9.213

4.  Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.

Authors:  Sarah E Monsell; Danping Liu; Sandra Weintraub; Walter A Kukull
Journal:  Int Psychogeriatr       Date:  2012-04-16       Impact factor: 3.878

5.  Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study.

Authors:  M F Elias; P K Elias; L M Sullivan; P A Wolf; R B D'Agostino
Journal:  Int J Obes Relat Metab Disord       Date:  2003-02

6.  High total cholesterol levels in late life associated with a reduced risk of dementia.

Authors:  M M Mielke; P P Zandi; M Sjögren; D Gustafson; S Ostling; B Steen; I Skoog
Journal:  Neurology       Date:  2005-05-24       Impact factor: 9.910

7.  Midlife and late-life obesity and the risk of dementia: cardiovascular health study.

Authors:  Annette L Fitzpatrick; Lewis H Kuller; Oscar L Lopez; Paula Diehr; Ellen S O'Meara; W T Longstreth; José A Luchsinger
Journal:  Arch Neurol       Date:  2009-03

8.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

Review 9.  The Alzheimer's Disease Centers' Uniform Data Set (UDS): the neuropsychologic test battery.

Authors:  Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Apr-Jun       Impact factor: 2.703

10.  Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort.

Authors:  Anna-Maija Tolppanen; Tiia Ngandu; Ingemar Kåreholt; Tiina Laatikainen; Minna Rusanen; Hilkka Soininen; Miia Kivipelto
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

View more
  7 in total

1.  Lower CSF Amyloid-Beta1-42 Predicts a Higher Mortality Rate in Frontotemporal Dementia.

Authors:  Daniela Vieira; João Durães; Inês Baldeiras; Beatriz Santiago; Diana Duro; Marisa Lima; Maria João Leitão; Miguel Tábuas-Pereira; Isabel Santana
Journal:  Diagnostics (Basel)       Date:  2019-10-25

2.  Feasibility and acceptability of a multi-domain intervention to increase Mediterranean diet adherence and physical activity in older UK adults at risk of dementia: protocol for the MedEx-UK randomised controlled trial.

Authors:  Oliver M Shannon; Vivian Lee; Rafe Bundy; Rachel Gillings; Amy Jennings; Blossom Stephan; Michael Hornberger; George Balanos; Stella Maria Paddick; Sarah Hanson; Wendy Hardeman; Rebecca Holmes; Nikki Garner; Sarah Aldred; Mario Siervo; John C Mathers; Anne Marie Minihane
Journal:  BMJ Open       Date:  2021-02-05       Impact factor: 2.692

Review 3.  The interaction and pathogenesis between cognitive impairment and common cardiovascular diseases in the elderly.

Authors:  Wenhang Zuo; Jinhui Wu
Journal:  Ther Adv Chronic Dis       Date:  2022-02-02       Impact factor: 5.091

4.  Ventricular Repolarization is Associated with Cognitive Function, but Not with Cognitive Decline and Brain Magnetic Resonance Imaging (MRI) Measurements in Older Adults.

Authors:  Michelle H Zonneveld; Raymond Noordam; Jeroen van der Grond; Behnam Sabayan; Simon P Mooijaart; Peter W Mcfarlane; J Wouter Jukema; Stella Trompet
Journal:  J Clin Med       Date:  2020-03-26       Impact factor: 4.241

5.  A Suboptimal Diet is Associated with Poorer Cognition: The NUDAD Project.

Authors:  Jay L P Fieldhouse; Astrid S Doorduijn; Francisca A de Leeuw; Barbara J H Verhaar; Ted Koene; Linda M P Wesselman; Marian de van der Schueren; Marjolein Visser; Ondine van de Rest; Philip Scheltens; Maartje I Kester; Wiesje M van der Flier
Journal:  Nutrients       Date:  2020-03-06       Impact factor: 5.717

6.  The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship.

Authors:  Qingqin S Li; Chao Tian; David Hinds; Guy R Seabrook
Journal:  PLoS One       Date:  2020-11-05       Impact factor: 3.240

Review 7.  Metabolic Syndrome: Is It Time to Add the Central Nervous System?

Authors:  Milagros Rojas; Mervin Chávez-Castillo; Daniela Pirela; Heliana Parra; Manuel Nava; Maricarmen Chacín; Lissé Angarita; Roberto Añez; Juan Salazar; Rina Ortiz; Samuel Durán Agüero; Marbel Gravini-Donado; Valmore Bermúdez; Edgar Díaz-Camargo
Journal:  Nutrients       Date:  2021-06-30       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.